Abstract: Most human papillomavirus (HPV)-associated vulvar squamous cell carcinomas (VSCCs) originate from high-grade squamous intraepithelial lesions, also named usual type vulvar intraepithelial neoplasia. However, growing evidence suggests that morphologic studies have limitations in predicting HPV status in vulvar lesions. We aimed to evaluate adjacent intraepithelial lesions in a series of DNA HPV-positive VSCCs, focusing on unusual histologic patterns mimicking differentiated vulvar intraepithelial neoplasia (dVIN) or lichen sclerosus (LS). We identified 326 DNA HPV-positive VSCC with at least 1 cm of skin adjacent to the invasive tumor and analyzed HPV typing, HPV E6*I mRNA, and p16 immunohistochemistry in all cases. A careful histologic evaluation was conducted. A conclusive association with HPV was based on a positive p16 or HPV E6*I mRNA result or both in addition to the HPV DNA, whereas cases negative for both markers were classified as nonconclusively associated with HPV. One hundred twenty-one tumors (37.1%) had normal adjacent skin, 191 (58.6%) had only high-grade squamous intraepithelial lesions, also named usual type vulvar intraepithelial neoplasia, and unusual intraepithelial lesions were identified in 14 (4.3%) tumors. Seven cases showed dVIN-like features, 5 showed adjacent LS-like lesion, and in 2 cases dVIN-like and LS-like lesions were identified simultaneously. Six of them were conclusively associated with HPV (3 dVIN-like, 2 LS-like, 1 with combined dVIN/LS-like features). All 6 tumors were associated with HPV16 and were positive for both p16 and HPV mRNA, and p16 was also positive in the dVINlike and LS-like lesions. In summary, a small subset of VSCCs conclusively associated with HPV may arise on intraepithelial lesions, mimicking precursors of HPV-independent VSCC. 
I
t is widely accepted that most vulvar squamous cell carcinomas (VSCCs) originate from intraepithelial lesions that precede the development of VSCC by a variable period of time. [1] [2] [3] Each type of VSCC, that is, human papillomavirus (HPV)-associated and HPV-independent, not only has particular histologic features but is also associated with a distinct type of intraepithelial lesion. 3 Thus, HPV-associated VSCCs are usually of basaloid, warty, or nonkeratinizing subtype and arise from high-grade squamous intraepithelial lesions, also referred to as vulvar intraepithelial neoplasia of usual type (HSIL/uVIN), which have basaloid or warty features. In contrast, HPV-independent VSCCs, which are usually of a keratinizing subtype, derive from a premalignant lesion named differentiated vulvar intraepithelial neoplasia (dVIN) and are frequently associated with chronic inflammatory lesions, especially lichen sclerosus (LS). 1, 2 However, this correlation between histologic features and HPV involvement is not always the rule. Indeed, a number of studies indicate that these features have a limited usefulness to determine HPV status. [3] [4] [5] [6] Thus, the presence of keratinizing, basaloid, warty features, or koilocytotic changes is highly unreliable to classify the tumor as HPV-associated or HPV-independent. 5 The problem is further stressed by the occasional overlap between the premalignant lesions, as in a small percentage of cases the precursors of HPV-independent VSCC may closely simulate HSIL/uVIN. 7, 8 A recent meta-analysis has estimated that the pooled prevalence of HPV-related dVIN-like lesions is about 2%. 9 However, no study has specifically addressed the description of these dVIN-like intraepithelial lesions in HPVassociated VSCC.
In this study, we aimed to evaluate adjacent intraepithelial lesions in a large series of 326 VSCC cases positive for DNA HPV, focusing on unusual histologic patterns such as intraepithelial lesions resembling dVIN and/or LS, the skin lesions typically related to HPV-independent VSCC. We analyzed their correlation with the HPV DNA genotype, p16 immunohistochemistry, and HPV mRNA.
MATERIALS AND METHODS

Case Selection
We reviewed a series of 1709 invasive VSCCs included in the VVAP study (International Survey on HPV prevalence and type distribution in vulvar, vaginal, anal, penile neoplasia) coordinated by the Catalan Institute of Oncology (ICO, Barcelona, Spain) in collaboration with DDL Diagnostics Laboratory (Rijswijk, the Netherlands). 10 We selected all cases fulfilling the following inclusion criteria: (1) invasive squamous carcinoma identified in the block; (2) adequate material for histologic analysis, HPV detection and typing, and p16 immunohistochemical staining; (3) a positive result for HPV detection by polymerase chain reaction (PCR); and (4) the presence of at least 1 cm of skin adjacent to the invasive tumor. The study was approved by the local and ICO Ethics Committees. Three hundred twenty-six cases fulfilled the inclusion criteria.
Tissue Preparation, Nucleic Acid Isolation, and HPV DNA Detection DNA extraction was performed on whole sections of formalin-fixed paraffin-embedded tissue, from surgical specimens or vulvar biopsies, as previously described. 5, 10 Sectioning and sample preparation were carried out with the highest safety measures to avoid cross-contamination. Processing and pathology diagnosis were carried out by the ICO laboratory.
HPV DNA detection was performed, using SPF10 PCR, DEIA, and the LiPA25 system (version 1; Laboratory Biomedical Products, Rijswijk, the Netherlands), as previously described. 5, 10 Each run contained negative and positive controls to monitor the efficiency of DNA isolation, PCR amplification, hybridization, and genotyping procedures.
E6*I mRNA Reverse Transcription-PCR
Extraction and HPV mRNA detection from tissue ribbons were performed as previously described. 5 p16 Immunohistochemistry
All tumors were stained with p16 monoclonal antibody using the CINtec Histology Kit (clone E6H4; Rochemtm-Laboratories, Heidelberg, Germany). 12 Only cases showing strong and diffuse block staining of the basal and suprabasal layers, involving at least the lower third of the epithelium and a minimum of 20 contiguous horizontal cells, were considered as positive (p16 upregulation). 13 The p16 staining was evaluated independently in the invasive tumor, in the intraepithelial lesion/s, and in the normal skin.
Classification of the Lesions as Conclusively and Nonconclusively Associated With HPV
A case was classified as conclusively associated with HPV when it was positive for HPV DNA in the invasive tumor and had a positive staining for p16 immunohistochemistry, was positive for HPV mRNA, or both. Nonconclusive association with HPV was defined as the identification of HPV DNA in the invasive tumor with negative staining for p16 immunohistochemistry and a negative result for HPV mRNA. Tumors in which only a low-risk or an undetermined HPV type were identified were analyzed independently, as HPV mRNA assays were not developed for these viruses.
Histologic Evaluation
A single histologic slide of each case was available for review. Histologic evaluation was blind to HPV DNA and genotyping, HPV mRNA, and p16 immunohistochemistry results. Invasive squamous carcinoma was confirmed in all the 326 cases. The VSCC were classified into keratinizing, basaloid, warty, or nonkeratinizing subtypes following the WHO 2014 classification. 14 The squamous epithelium adjacent to the neoplasms was carefully evaluated in search of associated pathology. In order to establish the diagnosis of intraepithelial lesion, the lesion had to be present at least 10 mm away from the invasive carcinoma to rule out possible peripheral intraepithelial extension simulating HSIL/uVIN or dVIN. The adjacent HSIL/uVIN was classified as a basaloid or warty subtype. Briefly, the basaloid type HSIL/uVIN was characterized by small atypical cells throughout the whole epidermis with a striking architectural disarray. 2 Warty type HSIL/uVIN was diagnosed when the epidermis had wide and deep rete ridges, clear pleomorphism, and easily recognizable koilocytotic-like changes suggestive of HPV infection. 3 A dVIN-like lesion was defined by the presence of atypical keratinocytes limited to the basal and parabasal layers in the context of a fully differentiated epithelium. 3 LS-like lesions were diagnosed in cases where homogenization of the collagen was clearly evident, alongside other features described elsewhere. 1 The adjacent skin was considered normal in the absence of HSIL/uVIN, dVIN-like lesions, and/or LS-like changes.
RESULTS
The adjacent skin was normal in 121/326 VSCC (37.1%), whereas 205/326 (62.9%) showed at least 1 intraepithelial precursor lesion in the adjacent skin. HSIL/ uVIN (warty or basaloid type) was observed as the only precursor lesion in 191 of 326 tumors (58.6%). Unusual intraepithelial lesions, that is, dVIN-like and/or LS-like lesions, were identified in the adjacent skin in 14 tumors (4.3%). Figure 1 shows the study algorithm. Table 1 shows the associated intraepithelial lesions identified in the adjacent skin for each specific HPV type in the whole series of 326 cases.
The HPV mRNA results were available in 304 of the 326 tumors included in the series. Overall, 281/304 VSCCs, in which all the tests (HPV DNA, HPV mRNA, and p16 results) were available, were considered as conclusively associated with high-risk HPV. Among the VSCCs conclusively associated with HPV, 261 (92.9%) were positive for both p16 and HPV mRNA, 11 (3.9%) were positive only for p16, and 9 (3.2%) were positive only ∥Includes (a) double infection by HPV6 and 16 (n = 3); HPV16 and 18 (n = 1); HPV16 and 31 (n = 1); HPV16 and 33 (n = 1); HPV16 and 51 (n = 1); HPV18 and 11 (n = 1); HPV18 and 74 (n = 1); HPV31 and 33 (n = 1); HPV33 and 56 (n = 1); HPV35 and 66 (n = 1); HPV51, 68-73 (n = 1); HPV42 and 70 (n = 1); (b) triple infections HPV31, 33, and 58 (n = 1); and (c) quadruple infections HPV31, 33, 44, and 45 (n = 1).
¶Nonconclusive association with HPV defined as the identification of HPV DNA in the invasive tumor with negative staining for p16 immunohistochemistry and a negative HPV mRNA result.
#Includes infections by HPV31 (2 cases), 51 (1 case), and 52 (2 cases). **Includes (a) double infection by HPV16 and 18 (n = 1); HPV44 and 58 (n = 1); and HPV44 and 66 (n = 1) and (b) quadruple infection by HPV51, 53, 54, and 58 (n = 1).
† †Includes: single infection by HPV6 (n = 1), HPV11 (n = 1), 44 (n = 3), 61 (n = 2), and 74 (n = 1).
for HPV mRNA. Twenty-four tumors were considered as nonconclusively associated with HPV because of negative p16 and HPV mRNA results. One hundred eighty-seven of the 281 (66.5%) tumors conclusively associated with HPV showed HSIL/uVIN in the adjacent skin, whereas only 3/24 (12.5%) of the tumors with a nonconclusive association had adjacent HSIL/uVIN lesions (P < 0.001). The skin precursor was also positive for p16 in all the p16-positive tumors showing HSIL/uVIN.
Among the 21 tumors with a low-risk or undetermined HPV type identified, 1 with a low-risk HPV (HPV44) had adjacent HSIL/uVIN, with both the invasive tumor and the HSIL/uVIN being negative for p16. Two tumors with an HPV of undetermined type showed adjacent HSIL/uVIN and were positive for p16.
Unusual Intraepithelial Lesions
Fourteen samples showed unusual intraepithelial lesion adjacent to the DNA HPV-positive VSCC. Seven cases (7/326; 2.1%) showed dVIN-like features, 5 cases (1.5%) showed adjacent LS-like lesions, and, in 2 cases (0.6%), dVINlike and LS-like lesions were identified simultaneously. Finally, in 1 case (0.3%), LS-like features were identified in combination with typical HSIL/uVIN. Table 2 shows the age, the results of the p16 immunohistochemistry study of the tumor and the precursor lesion and HPV mRNA, the other associated skin lesions, and the histologic subtyping of the invasive tumor of all the cases with dVIN-like, LS-like, or both lesions.
Six cases were conclusively associated with HPV (3 dVIN-like lesions, 2 LS-like lesions, 1 with combined dVIN/LS-like lesions). All were associated with HPV16 and were positive for both p16 and HPV mRNA. In all cases, the p16 was also positive in the adjacent dVIN-like lesion. Similarly, in the 3 cases with LS-like lesions, the skin overlying the LS-like area showed block positivity for p16, at least focally.
Another group of 8 cases consisted of tumors with nonconclusive association with HPV and tumors caused by low-risk or undetermined HPV. All were positive for HPV DNA but were negative for p16 both in the tumor and in the precursor lesions. In all these cases, the HPV mRNA was either negative or not tested.
dVIN-like and LS-like Lesions in Tumors Conclusively Associated With HPV
In all dVIN-like cases identified in tumors conclusively associated with HPV, atypical keratinocytes were identified in a fully differentiated epithelium, with atypia strictly limited to the basal and parabasal layers, and with cells having abundant eosinophilic cytoplasm (Figs. 2A, B , cases number 1 and 3 in the Table 2 , respectively). The epithelium was atrophic or acanthotic with superficial parakeratosis. The rete ridges were elongated and branched. The keratinocytes in the epidermis were enlarged, had prominent desmosomes, abundant eosinophilic cytoplasm, large vesicular nuclei, and macronucleoli. No extension to skin appendages was identified. None of these cases had the typical whole epithelial thickness architectural disarray, prominent cytologic atypia, and nuclear pleomorphism typical of HSIL/ uVIN. A moderate lymphocytic infiltrate was present in the papillary dermis. In all cases, p16 showed diffuse block staining in the dVIN-like lesion with nuclear and cytoplasmic positivity involving at least the basal and suprabasal layers (Figs. 2A', B' ).
LS-like lesions were characterized by broad condensation and hyalinization of the dermal collagen in the papillary dermis (Fig. 3A , case number 5 in the Table 2 ). The epidermis showed slight to moderate hyperkeratosis. In contrast with typical LS lesions, the rete ridges appeared elongated. In the 2 cases, p16 showed diffuse block staining in the epithelium overlying the hyalinized dermal collagen (Fig. 3A' ). One case showed combined LS-like (hyalinization of the dermal collagen in the papillary dermis) and dVINlike lesions (atypia limited to the basal and parabasal layers in a fully differentiated epithelium with elongated rete ridges) (Fig. 3B , case number 4 in the Table 2 ). The epithelium showed block positivity for p16.
DISCUSSION
In this study, we confirm that a subset of VSCC conclusively associated with HPV arises on intraepithelial lesions that have dVIN-like morphologic features. In all of these cases, the association with HPV was conclusively established by positive HPV DNA result as well as the detection of HPV mRNA and a positive p16 result. Interestingly, in all these lesions p16 immunohistochemistry showed "block positivity," both in the invasive tumor and in the intraepithelial lesion, a characteristic finding in HSIL/uVIN lesions. These findings indicate that HSIL/ uVIN could have a wider morphologic spectrum than traditionally accepted, with some lesions having a dVINlike morphology. The proportion of these cases was very low, as this morphology was identified in only 4 of 281 tumors conclusively associated with HPV (1.4%). However, this distinction may be clinically relevant, as vulvar HSIL/uVIN has a low progression potential and may regress spontaneously, [15] [16] [17] whereas dVIN has shown a high potential for malignant transformation. 8, 18 Moreover, the identification of dVIN-like areas at the periphery in a VSCC may be considered as indirect evidence of an HPVindependent vulvar cancer. 19 Interestingly, most of the women with VSCC conclusively associated with HPV with dVIN-like lesions were relatively old, a clinical characteristic typical of HPV-independent lesions. This unusual pattern of HSIL/uVIN has not specifically been described previously. Nevertheless, a thorough review of the literature identified 2 possible additional cases. Yang and Hart 20 analyzed 12 cases of dVIN by PCR and/or in situ hybridization (ISH) for various HPV types, and identified 1 case positive for HPV type 31/35/51 by ISH. The lesion was negative for p53 immunohistochemistry, and the patient had multifocal intraepithelial lesions, some of which showed histologic features overlapping with HSIL/uVIN. Similarly, Haefner et al 21 identified HPV in 1 of 7 cases of dVIN tested by PCR and ISH. Finally, a recent meta-analysis has estimated that the pooled prevalence of HPV-related dVIN-like lesions is about 2%. 9 The existence of HSIL/uVIN lesions with dVIN-like histologic features is not surprising, because morphology studies have shown clear limitations in classifying vulvar tumors as HPV-associated or HPV-independent. [3] [4] [5] [6] In addition, we have previously described that a small percentage of HPV-independent VSCC have adjacent intraepithelial lesions with histologic features mimicking basaloid type HSIL/uVIN. 4, 7 Finally, a number of studies have reported occasional lesions with overlapping morphologic features of HSIL/uVIN and dVIN, although most include either HPV-independent tumors or HPV detection was not made or was not reliable. 8, 20, 22 In our study we found a strong correlation between the presence of high-risk viral type and adjacent HSIL/ uVIN, which was present in 66.8% of the tumors. These results are in keeping with previous studies describing a strong association between high-risk viral type HSIL/ uVIN and VSCC. 4, 19, 23 The percentage of HSIL/uVIN was similar for all tumors conclusively associated with HPV independently of the high-risk HPV type (and also with multiple infections) and ranged between 40% and 70%. In contrast, the percentage of HSIL/uVIN in tumors in which low-risk or undetermined HPV were detected was very low.
The low percentage of tumors nonconclusively associated with HPV (positive for HPV DNA, but negative for both p16 and HPV mRNA) that were associated with HSIL/uVIN lesions was of note in our study. These findings suggest that many of these cases represent false positives for HPV DNA and are in keeping with the previously proposed criteria that HPV DNA alone should not be considered as sufficient evidence of HPV-association, unless a second marker (p16 or HPV mRNA) is also detected. 5, 10 The almost constant positivity for p16, both in the conclusively HPV-associated tumors and the adjacent intraepithelial lesion, indicates that this marker can confidently be used as an HPV surrogate. 4, 5, 10 The presence of LS-like changes in 3 tumors conclusively associated with HPV (2 cases with LS-like lesions and 1 with coincident dVIN/LS-like lesions) is striking. Although this coincidence could be largely circumstantial, and a woman with LS can be infected with HPV and also develop HSIL/uVIN, and subsequently, basaloid or warty VSCC, the block positivity for p16 in the skin overlying the LS-like lesions in all 3 tumors, even in skin with no atypical features, raises the question of the presence of LS features in some HPV-associated intraepithelial lesions or the possible implication of HPV in the development of LS. A few studies have reported the presence of HPV in the epithelium with LS changes 24 in HPV-associated VSCC, and it seems that these cases have fewer mutations than conventional HPV-negative LS. 25 The pathogenesis of the VSCC in which low-risk (HPV44) or undetermined HPV type was detected is uncertain. Although HPV44 is infrequent and considered to be of a low-risk viral type, it has occasionally been linked to the development of anogenital carcinomas through different mechanisms, without p16 overexpression. 26 However, the role of this HPV type is not well understood. To date, only 1 case of vulvar carcinoma of warty/basaloid morphology, in which HPV44 was detected, has been reported. 26 The main limitation of the present series is that HPV DNA or mRNA was only analyzed in the whole paraffin block containing both the precursor and the invasive tumor. Consequently, the possibility of a dVIN or LS lesion, not related to the tumor, growing in the vicinity of a VSCC conclusively associated with HPV cannot be completely ruled out. However, the diffuse "block staining" for p16 identified in the dVIN-like lesions indicates that this hypothesis is rather unlikely. A second limitation is that we did not study p53, which is frequently positive in dVIN. 20 However, p53 immunohistochemistry has proven to be unreliable to differentiate dVIN and HSIL/uVIN lesions. 27 Nevertheless, in most of our cases a clear association with HPV16 was demonstrated, and the dVIN-like lesions showed clear staining for p16, an unusual feature in HPV-negative dVIN. 28 In conclusion, in this large series of HPV-positive VSCCs with adjacent skin, we found that a small proportion of tumors conclusively associated with HPV may arise in intraepithelial lesions that closely simulate dVIN and LS, the intraepithelial precursors of HPV-independent VSCC. Awareness of this unusual feature may help to correctly classify these lesions as HPV-associated. In addition, p16 staining is an excellent surrogate marker of HPV infection 29 and may help to identify these infrequent lesions.
